Regax

Regax is an independent consultancy specialised in market access, pricing, reimbursement, and stakeholder engagement for pharmaceutical and MedTech companies. 
With over 25 years of experience at Benelux (+15 years in BE pharma , +5 years in NL pharma), EU and global level, Regax supports organisations in successfully navigating complex healthcare systems.

The company is led by Veronique Wyffels, an experienced market access and regulatory affairs professional with a background as a hospital pharmacist and health economist. 
Her broad international expertise enables Regax (website: www.regax.be) to translate clinical evidence and value propositions into effective access and lifecycle strategies.

Regax works closely with clients through a pragmatic, evidence-based and stakeholder-centric approach to achieve sustainable market access.

Core services include for both the Belgian Market, the Dutch Market or JCA dossiers:

• Market access and pricing strategy development
• Landscape analysis
• Reimbursement and pricing dossier writing and review
• Stakeholder mapping and stakeholder engagement
• Early advice meetings , Advisory boards and preparation for Hearings
• Health economic evidence (adaptation of a HE model and/or Budgetary impact model)  and value communication
• Contract negotiations
• Clinical Regulatory insight and advisory support
• Tailored training and hands-on consultancy

Regax partners with both innovative startups and established life sciences companies, offering flexible, customised support to accelerate access and strengthen market positioning.